Investigating the role of immune cells in childhood brain tumors

The role of Myeloid cells in pediatric-high grade gliomas

NIH-funded research Icahn School of Medicine at Mount Sinai · NIH-11099934

This study is looking at how certain immune cells in the brain, called macrophages and neutrophils, affect a type of brain cancer in kids, and it hopes to find new ways to help treat these young patients better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11099934 on NIH RePORTER

What this research studies

This research focuses on understanding how myeloid cells, particularly tumor-associated macrophages and neutrophils, contribute to pediatric high-grade gliomas, a type of brain cancer in children. By analyzing tissue samples from patients and using advanced RNA sequencing techniques, the researchers aim to uncover the unique characteristics of these immune cells in pediatric tumors compared to adult cases. The study seeks to identify potential therapeutic targets that could improve treatment outcomes for affected children.

Who could benefit from this research

Good fit: Ideal candidates for this research are children diagnosed with pediatric high-grade gliomas, particularly those with specific genetic mutations or inflammatory profiles.

Not a fit: Patients with low-grade gliomas or other types of brain tumors may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve survival rates for children with high-grade gliomas.

How similar studies have performed: Previous research has shown promising results in targeting immune cells in adult gliomas, suggesting potential for similar success in pediatric cases.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agentsanti-cancer drug
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.